Powered by Google Google ÜbersetzerGoogle Übersetzer
Originaltext
Diese Übersetzung bewerten
Mit deinem Feedback können wir Google Übersetzer weiter verbessern
Latest Press Releases
View all
TimeHeadline
26m agoNayax to Report 2026 Q1 Earnings on May 12, 2026
53m agoCC Capital and OneIM Complete Acquisition of Insignia Financial Limited, Australia's Leading Diversified Wealth Management Group
1h agoCanadian Gold Resources Strengthens Board with Capital Markets Veteran Kenneth Chernin
1h agoWaraba Gold Signs Binding Agreement to Establish Joint Venture Relating to Tengrela South Exploration Permit Application in Cote d'Ivoire
1h agoSierra Madre Announces Shareholder Approval of Acquisition of Del Toro Silver Mine

Drugs Made In America Acquisition Corp. Units

About

Drugs Made In America Acquisition Corp. Units (NASDAQ:DMAAU) — investor relations, events, news, and company updates on 6ix.

Latest News

Feb 24 2025
Drugs Made in America Acquisition Corp. Announces Advisory Team
Feb 20 2025
Drugs Made In America Acquisition Corp. Announces the Separate Trading of its Ordinary Shares and Rights, Commencing February 25, 2025
Feb 18 2025
Drugs Made In America Acquisition Corp. Announces Closing of Full Exercise of IPO Over-Allotment Option
Jan 29 2025
Drugs Made In America Acquisition Corp. Announces Closing of $200,000,000 Initial Public Offering
Jan 27 2025
Drugs Made In America Acquisition Corp. Announces Pricing of $200,000,000 Initial Public Offering

Financials

Revenue
$0
Market Cap
$308.64 M

Community Chat

Ask AI

6ix6ixAIEvents